Pharmacologic resuscitation for hemorrhagic shock combined with traumatic brain injury

Journal of Trauma and Acute Care Surgery

Volumn 73, Issue 6, 2012, Pages 1461-1470

  Jin, Guang ^a,c   Duggan, Michael ^a   Imam, Ayesha ^a   Demoya, Marc A ^a   Sillesen, Martin ^a   Hwabejire, John ^a   Jepsen, Cecilie H ^a   Liu, Baoling ^a,c   Mejaddam, Ali Y ^a   Lu, Jennifer ^a   Smith, William Michael ^a   Velmahos, George C ^a   Socrate, Simona ^b   Alam, Hasan B ^a,c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^c UNIVERSITY OF MICHIGAN HOSPITALS   (United States)

Author keywords

Brain; resuscitation; swine; trauma; valproic acid

Indexed keywords

CD11B ANTIGEN; HETASTARCH; HISTONE H3; INTERLEUKIN 1BETA; MYELOPEROXIDASE; SODIUM CHLORIDE; VALPROIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN EDEMA; BRAIN HYPOXIA; BRAIN OXYGEN CONSUMPTION; CONTROLLED STUDY; CRANIOTOMY; DRUG BLOOD LEVEL; EXPERIMENTAL PIG; FEMALE; HEMODYNAMIC PARAMETERS; HEMORRHAGIC SHOCK; HISTONE ACETYLATION; INTRACRANIAL PRESSURE; MONITORING; NONHUMAN; PRIORITY JOURNAL; RESUSCITATION; TRAUMATIC BRAIN INJURY; UPREGULATION;

ANIMALS; BRAIN INJURIES; DISEASE MODELS, ANIMAL; DRUG THERAPY, COMBINATION; FEMALE; HEMODYNAMICS; HETASTARCH; INFLAMMATION; ISOTONIC SOLUTIONS; RESUSCITATION; SHOCK, HEMORRHAGIC; SWINE; VALPROIC ACID;

EID: 84871230264     PISSN: 21630755     EISSN: 21630763     Source Type: Journal    
DOI: 10.1097/TA.0b013e3182782641     Document Type: Article

References (50)

1. Rhind SG, Crnko NT, Baker AJ, Morrison LJ, Shek PN, Scarpelini S, Rizoli SB. Prehospital resuscitation with hypertonic saline-dextran modulates inflammatory, coagulation and endothelial activation marker profiles in severe traumatic brain injured patients. J Neuroinflammation. 2010;7:5.
2. Chesnut RM, Marshall LF, Klauber MR, Blunt BA, Baldwin N, Eisenberg HM, Jane JA, Marmarou A, Foulkes MA. The role of secondary brain injury in determining outcome from severe head injury. J Trauma. 1993; 34:216-222.
3. Jenkins LW, Moszynski K, Lyeth BG, Lewelt W, DeWitt DS, Allen A, Dixon CE, Povlishock JT, Majewski TJ, Clifton GL, et al. Increased vulnerability of the mildly traumatized rat brain to cerebral ischemia: the use of controlled secondary ischemia as a research tool to identify common or different mechanisms contributing to mechanical and ischemic brain injury. Brain Res. 1989;477:211-224.
4. Matsushita Y, Bramlett HM, Kuluz JW, Alonso O, Dietrich WD. Delayed hemorrhagic hypotension exacerbates the hemodynamic and histopathologic consequences of traumatic brain injury in rats. J Cereb Blood Flow Metab. 2001;21:847-856.
5. Myburgh J, Cooper DJ, Finfer S, Bellomo R, Norton R, Bishop N, Kai Lo S, Vallance S. Saline or albumin for fluid resuscitation in patients with traumatic brain injury. N Engl J Med. 2007;357:874-884.
6. Crookes BA, Cohn SM, Bonet H, Burton EA, Nelson J, Majetschak M, Varon AJ, Linden JM, Proctor KG. Building a better fluid for emergency resuscitation of traumatic brain injury. J Trauma. 2004;57:547-554.
7. King DR, Cohn SM, Proctor KG. Changes in intracranial pressure, coagulation, and neurologic outcome after resuscitation from experimental traumatic brain injury with hetastarch. Surgery. 2004;136:355-363.
8. Peiniger S, Nienaber U, Lefering R, Braun M, Wafaisade A, Wutzler S, Borgmann M, Spinella PC, Maegele M. Balanced massive transfusion ratios in multiple injury patients with traumatic brain injury. Crit Care. 2011;15:R68.
9. Jin G, Duggan M, Kasotakis G, Knightly T, Mejaddam AY, Hwabejire J, Lu J, Smith WM, deMoya MA, Velmahos GC, et al. traumatic brain injury and hemorrhagic shock: evaluation of different resuscitation strategies in a large animal model of combined insults.
10. Alam HB, Hamwi KB, Duggan M, Fikry K, Lu J, Fukudome EY, ChongW, Bramos A, Kim K, Velmahos G. Hemostatic and pharmacologic resuscitation: results of a long-term survival study in a swine polytrauma model. J Trauma. 2011;70:636-645.
11. Gonzales ER, Chen H, Munuve RM, Mehrani T, Nadel A, Koustova E. Hepatoprotection and lethality rescue by histone deacetylase inhibitor valproic acid in fatal hemorrhagic shock. J Trauma. 2008;65:554-565.
12. Shults C, Sailhamer EA, Li Y, Liu B, Tabbara M, Butt MU, Shuja F, Demoya M, Velmahos G, Alam HB. Surviving blood loss without fluid resuscitation. J Trauma. 2008;64:629-638; discussion 638-640.
13. Alam HB, Shuja F, ButtMU, Duggan M, Li Y, Zacharias N, Fukudome EY, Liu B, Demoya M, Velmahos GC. Surviving blood loss without blood transfusion in a swine poly-trauma model. Surgery. 2009;146:325-333.
14. Ichiyama T, Okada K, Lipton JM, Matsubara T, Hayashi T, Furukawa S. Sodium valproate inhibits production of TNF-alpha and IL-6 and activation of NF-kappaB. Brain Res. 2000;857:246-251.
15. Kim K, Li Y, Jin G, ChongW, Liu B, Lu J, Lee K, Demoya M, Velmahos G, Alam HB. Effect of valproic acid on acute lung injury in a rodent model of intestinal ischemia reperfusion. Resuscitation. 2012;83:243-248.
16. Zhang Z, Zhang ZY, Fauser U, Schluesener HJ. Valproic acid attenuates inflammation in experimental autoimmune neuritis. Cell Mol Life Sci. 2008;65:4055-4065.
17. Yu CH, Yhee JY, Kim JH, Im KS, Kim NH, Jung DI, Lee HC, Chon SK, Sur JH. Pro- and anti-inflammatory cytokine expression and histopathological characteristics in canine brain with traumatic brain injury. J Vet Sci. 2011;12:299-301.
18. Li B, Mahmood A, Lu D, Wu H, Xiong Y, Qu C, Chopp M. Simvastatin attenuates microglial cells and astrocyte activation and decreases interleukin- 1beta level after traumatic brain injury. Neurosurgery. 2009;65: 179-185; discussion 185-186.
19. Li Y, Yuan Z, Liu B, Sailhamer EA, Shults C, Velmahos GC, Demoya M, Alam HB. Prevention of hypoxia-induced neuronal apoptosis through histone deacetylase inhibition. J Trauma. 2008;64:863-870; discussion 870-871.
20. Prevost TP, Jin G, Demoya MA, Alam HB, Suresh S, Socrate S. Dynamic mechanical response of brain tissue in indentation in vivo, in situ and in vitro. Acta Biomater. 2011.
21. Bourguignon PR, Shackford SR, Shiffer C, Nichols P, Nees AV. Delayed fluid resuscitation of head injury and uncontrolled hemorrhagic shock. Arch Surg. 1998;133:390-398.
22. Jin G, Tsuji K, Xing C, Yang YG, Wang X, Lo EH. CD47 gene knockout protects against transient focal cerebral ischemia in mice. Exp Neurol. 2009;217:165-170.
23. Takano K, Tatlisumak T, Formato JE, Carano RA, Bergmann AG, Pullan LM, Bare TM, Sotak CH, Fisher M. Glycine site antagonist attenuates infarct size in experimental focal ischemia. Postmortem and diffusion mapping studies. Stroke. 1997;28:1255-1262; discussion 1263.
24. Jin G, Sun PZ, Singhal AB, Ayata C, Lo EH. First-order mathematical modeling of brain swelling in focal cerebral ischemia. Transl Stroke Res. 2010;1:65-70.
25. Beaumont A, Marmarou A, Czigner A, Yamamoto M, Demetriadou K, Shirotani T, Marmarou C, Dunbar J. The impact-acceleration model of head injury: injury severity predicts motor and cognitive performance after trauma. Neurol Res. 1999;21:742-754.
26. Yamamoto M, Marmarou CR, Stiefel MF, Beaumont A, Marmarou A. Neuroprotective effect of hypothermia on neuronal injury in diffuse traumatic brain injury coupled with hypoxia and hypotension. J Neurotrauma. 1999;16:487-500.
27. Navarro JC, Pillai S, Cherian L, Garcia R, Grill RJ, Robertson CS. Histopathological and behavioral effects of immediate and delayed hemorrhagic shock after mild traumatic brain injury in rats. J Neurotrauma. 2012;29:322-334.
28. Exo JL, Shellington DK, Bayir H, Vagni VA, Janesco-Feldman K, Ma L, Hsia CJ, Clark RS, Jenkins LW, Dixon CE, et al. Resuscitation of traumatic brain injury and hemorrhagic shock with polynitroxylated albumin, hextend, hypertonic saline, and lactated Ringer's: effects on acute hemodynamics, survival, and neuronal death in mice. J Neurotrauma. 2009;26: 2403-2408.
29. Butcher I, Maas AI, Lu J, Marmarou A, Murray GD, Mushkudiani NA, McHugh GS, Steyerberg EW. Prognostic value of admission blood pressure in traumatic brain injury: results from the IMPACT study. J Neurotrauma. 2007;24:294-302.
30. Grande PO, Asgeirsson B, Nordstrom CH. Physiologic principles for volume regulation of a tissue enclosed in a rigid shell with application to the injured brain. J Trauma. 1997;42(suppl 5):S23-S31.
31. Tu YK, Heros RC, Candia G, Hyodo A, Lagree K, Callahan R, Zervas NT, Karacostas D. Isovolemic hemodilution in experimental focal cerebral ischemia. Part 1: effects on hemodynamics, hemorheology, and intracranial pressure. J Neurosurg. 1988;69:72-81.
32. Ohtaki M, Tranmer BI. Role of hypervolemic hemodilution in focal cerebral ischemia of rats. Surg Neurol. 1993;40:196-206.
33. Fukudome EY, Kochanek AR, Li Y, Smith EJ, Liu B, Kheirbek T, Lu J, Kim K, Hamwi K, Velmahos GC, et al. Pharmacologic resuscitation promotes survival and attenuates hemorrhage-induced activation of extracellular signal-regulated kinase 1/2. J Surg Res. 2010;163:118-126.
34. Li Y, Alam HB. Creating a pro-survival and anti-inflammatory phenotype by modulation of acetylation in models of hemorrhagic and septic shock. Adv Exp Med Biol. 2012;710:107-133.
35. Soriano SG, Piva S. Central nervous system inflammation. Eur J Anaesthesiol Suppl. 2008;42:154-159.
36. Engelhardt B. Immune cell entry into the central nervous system: involvement of adhesion molecules and chemokines. J Neurol Sci. 2008; 274:23-26.
37. Maekawa K, Futami S, Nishida M, Terada T, Inagawa H, Suzuki S, Ono K. Effects of trauma and sepsis on soluble L-selectin and cell surface expression of L-selectin and CD11b. J Trauma. 1998;44:460-468.
38. Morganti-Kossmann MC, Satgunaseelan L, Bye N, Kossmann T. Modulation of immune response by head injury. Injury. 2007;38:1392-1400.
39. Kadhim HJ, Duchateau J, Sebire G. Cytokines and brain injury: invited review. J Intensive Care Med. 2008;23:236-249.
40. McKeating EG, Andrews PJ. Cytokines and adhesion molecules in acute brain injury. Br J Anaesth. 1998;80:77-84.
41. Goodman JC, Robertson CS, Grossman RG, Narayan RK. Elevation of tumor necrosis factor in head injury. J Neuroimmunol. 1990;30:213-217.
42. Maier B, Schwerdtfeger K, Mautes A, Holanda M, Muller M, Steudel WI, Marzi I. Differential release of interleukines 6, 8, and 10 in cerebrospinal fluid and plasma after traumatic brain injury. Shock. 2001;15:421-426.
43. Bartfai T, Sanchez-Alavez M, Andell-Jonsson S, Schultzberg M, Vezzani A, Danielsson E, Conti B. Interleukin-1 system in CNS stress: seizures, fever, and neurotrauma. Ann N Y Acad Sci. 2007;1113:173-177.
44. Carson MJ, Thrash JC, Walter B. The cellular response in neuroinflammation: the role of leukocytes, microglia and astrocytes in neuronal death and survival. Clin Neurosci Res. 2006;6:237-245.
45. Jin G, Bausch D, Knightly T, Liu Z, Li Y, Liu B, Lu J, ChongW, Velmahos GC, Alam HB. Histone deacetylase inhibitors enhance endothelial cell sprouting angiogenesis in vitro. Surgery. 2011;150:429-435.
46. Wang Z, Leng Y, Tsai LK, Leeds P, Chuang DM. Valproic acid attenuates blood-brain barrier disruption in a rat model of transient focal cerebral ischemia: the roles of HDAC and MMP-9 inhibition. J Cereb Blood Flow Metab. 2011;31:52-57.
47. Dash PK, Orsi SA, Zhang M, Grill RJ, Pati S, Zhao J, Moore AN. Valproate administered after traumatic brain injury provides neuroprotection and improves cognitive function in rats. PLoS One. 2010;5:e11383.
48. Shein NA, Grigoriadis N, Alexandrovich AG, Simeonidou C, Lourbopoulos A, Polyzoidou E, Trembovler V, Mascagni P, Dinarello CA, Shohami E. Histone deacetylase inhibitor ITF2357 is neuroprotective, improves functional recovery, and induces glial apoptosis following experimental traumatic brain injury. FASEB J. 2009;23:4266-4275.
49. Atmaca A, Al-Batran SE, Maurer A, Neumann A, Heinzel T, Hentsch B, Schwarz SE, Hovelmann S, Gottlicher M, Knuth A, et al. Valproic acid (VPA) in patients with refractory advanced cancer: a dose escalating phase I clinical trial. Br J Cancer. 2007;97:177-182.
50. Lheureux PE, Penaloza A, Zahir S, Gris M. Science review: carnitine in the treatment of valproic acid-induced toxicityVwhat is the evidence? Crit Care. 2005;9:431-440.